Explore

Egg Freezing Techniques Improve Fertility Options for Women

Egg Freezing Techniques Improve Fertility Options for Women

Egg Freezing Techniques Improve Fertility Options for Women

Jewish Fertility Foundation Secures $3M Grant from Marcus Foundation Amid Rising IVF Demand

Jewish Fertility Foundation Secures $3M Grant from Marcus Foundation Amid Rising IVF Demand

The Jewish Fertility Foundation (JFF) has received a $3 million grant from the Marcus Foundation, marking the largest donation in JFF's history. This funding comes as JFF experiences a significant increase in demand for in vitro fertilization (IVF) grants. The grant will support various operational needs, including employee salaries, benefits, and professional development. JFF, founded in 2015, has seen spikes in IVF demand due to various factors, including increased awareness and the use of assisted reproductive technology. The foundation is also piloting a program to provide substantial grants for gestational surrogacy, particularly benefiting LGBTQ+ families.

Jewish Fertility Foundation Secures $3M Grant Amid Rising IVF Demand

Jewish Fertility Foundation Secures $3M Grant Amid Rising IVF Demand

Jewish Fertility Foundation Secures $3M Grant Amid Rising IVF Demand

Marcus Foundation Donates $3 Million to Jewish Fertility Foundation Amid Rising Demand

Marcus Foundation Donates $3 Million to Jewish Fertility Foundation Amid Rising Demand

The Marcus Foundation has awarded a $3 million grant to the Jewish Fertility Foundation (JFF) to support its growing demand for in vitro fertilization (IVF) grants. This donation is the largest single gift in JFF's history and will be used to cover operational costs such as salaries, benefits, and marketing. The Atlanta-based JFF has seen a significant increase in demand for its services, attributed to heightened awareness and a rise in the use of assisted reproductive technology. The grant will also support a pilot program offering grants for gestational surrogacy, particularly benefiting LGBTQ+ Jewish families. JFF's model involves funding fertility treatments through local donors and partnerships with clinics across its ten locations nationwide.

Natural Cycles Defends Its Role as a Regulated Contraceptive Amid Hormone Hesitancy

Natural Cycles Defends Its Role as a Regulated Contraceptive Amid Hormone Hesitancy

In response to an article by Sophie Willis discussing the trend of women moving away from hormonal contraception, Eleonora Benhar Noccioli, vice president of science and data at Natural Cycles, has defended the app's status as a regulated contraceptive method. The article in question suggested that the Natural Cycles app is not a contraceptive method, which Noccioli argues is misleading. She emphasizes that Natural Cycles is a CE-marked medical device, supported by clinical evidence and regulatory review, designed and authorized as a contraceptive in the European Union and the UK. The app uses a fertility algorithm to analyze personal biomarker data, distinguishing it from general period-tracking apps that are not regulated for pregnancy prevention.

Advancements in Rare Neurology Drug Development Highlighted by GRIN Therapeutics

Advancements in Rare Neurology Drug Development Highlighted by GRIN Therapeutics

Advancements in Rare Neurology Drug Development Highlighted by GRIN Therapeutics

NHS Race and Health Observatory Expands Genomic Testing to Address Ethnic Health Inequalities

NHS Race and Health Observatory Expands Genomic Testing to Address Ethnic Health Inequalities

The NHS Race and Health Observatory has announced the expansion of genomic testing to include DPYD gene variants found in non-European ancestry groups. This initiative aims to address ethnic health inequalities in cancer care by screening for variants that affect the breakdown of fluoropyrimidine chemotherapy. The North West Genomic Laboratory Hub began screening for the c.557A>G variant in September 2025, which is prevalent in people of African ancestry. As a result, three patients have received personalized chemotherapy doses, reducing their risk of adverse drug reactions. The Observatory is also testing for a fifth variant at six other genomic hubs, following a systematic review that called for broader screening.

Natera Reports Positive Interim Analysis from Allogene's ALPHA3 Trial in Large B-Cell Lymphoma

Natera Reports Positive Interim Analysis from Allogene's ALPHA3 Trial in Large B-Cell Lymphoma

Natera Reports Positive Interim Analysis from Allogene's ALPHA3 Trial in Large B-Cell Lymphoma

Wavelet Medical Secures $7M for AI Fetal Brain Monitoring Expansion

Wavelet Medical Secures $7M for AI Fetal Brain Monitoring Expansion

Wavelet Medical Secures $7M for AI Fetal Brain Monitoring Expansion

Autoimmune Conditions Linked to Mental Illness: New Screening Efforts in New York

Autoimmune Conditions Linked to Mental Illness: New Screening Efforts in New York

Researchers at Columbia University are undertaking a project to screen individuals in New York state's psychiatric hospitals for biomarkers of autoimmune, metabolic, or genetic underpinnings of mental health conditions. This initiative aims to identify cases where autoimmune conditions may be driving mental illness, offering alternative treatment options. The project follows findings that antibodies attacking the brain can lead to conditions like schizophrenia and OCD, challenging traditional views on mental health.

Breast Cancer Drug Letrozole Shows Promise in Boosting IVF Success Rates

Breast Cancer Drug Letrozole Shows Promise in Boosting IVF Success Rates

Breast Cancer Drug Letrozole Shows Promise in Boosting IVF Success Rates

Jewish Fertility Foundation Secures $3M Grant from Marcus Foundation Amid Rising IVF Demand

Jewish Fertility Foundation Secures $3M Grant from Marcus Foundation Amid Rising IVF Demand

Jewish Fertility Foundation Secures $3M Grant from Marcus Foundation Amid Rising IVF Demand